The efficacy of islet transplantation is limited by poor graft vascularization. We herein demonstrated that microvesicles (MVs) released from endothelial progenitor cells (EPCs) enhanced human islet vascularization. After incorporation into islet endothelium and β-cells, EPC-derived MVs favored insulin secretion, survival, and revascularization of islets transplanted in SCID mice. MVs induced in vitro islet endothelial cell proliferation, migration, resistance to apoptosis, and organization in vessel-like structures. Moreover, MVs partially overcame the antiangiogenic effect of rapamycin and inhibited endothelial-leukocyte interaction via L-selectin and CD40. MVs were previously shown to contain defined patterns of mRNAs. Here we demonstrated that MVs carried the proangiogenic miR-126 and miR-296 microRNAs (miRNAs). MVs pretreated with RNase or derived from Dicer knocked-down EPCs showed a reduced angiogenic effect. In addition, MVs overcame the antiangiogenic effect of the specific antagomiRs of miR-126 and miR-296, suggesting a relevant contribution of miRNAs delivered by MVs to islet endothelium. Microarray analysis of MV-stimulated islet endothelium indicated the upregulation of mRNAs coding for factors involved in endothelial proliferation, differentiation, and angiogenesis. In addition, MVs induced the activation of the PI3K-Akt and eNOS signaling pathways in islet endothelium. These results suggest that MVs activate an angiogenic program in islet endothelium that may sustain revascularization and β-cell function.
INTRODUCTION
ischemia and myocardial infarction (2, 43) . Moreover, recipient EPCs are able to chimerize with donor vessels in transplanted organs, suggesting a putative role in graft Islet transplantation is a suitable therapeutic option for type 1 diabetes (6, 44) . However, a great percentage revascularization (25, 39) . It has been previously shown that EPCs are recruited to the pancreas in response to of transplanted islets fail to engraft into the liver, and pancreata from multiple donors are still necessary to islet injury and that EPC-mediated pancreas neovascularization may facilitate the recovery of injured β-cells, achieve insulin independence (6) . A poor vascular engraftment is one of the main causes of islet loss.
improving islet allograft function (29). In addition, the increase of EPCs in the peripheral circulation after granTherefore, the identification of factors able to enhance neoangiogenesis may increase the success of islet transulocyte-macrophage colony-stimulating factor-induced mobilization resulted in an increase of vascular density plantation. It has been suggested that bone marrowderived endothelial progenitor cells (EPCs) specifically and engraftment in a murine model of islet transplantation (17) . localize within sites of endothelial injury and induce a regenerative program (49) . Indeed, EPC infusion exerts Several studies suggested that EPCs promote angiogenesis without a direct contribution in the formation protective effect in experimental models of hindlimb of vessels, but rather by a paracrine mechanism (37).
αVβ3 integrin, α6 integrin (BioLegend, San Diego, CA), and human leukocyte antigen (HLA) class I and II Exosomes/microvesicles (MVs) are thought to play an important role in cell-to-cell communication (12, 30, 40) .
(Santa Cruz Biotech., Santa Cruz, CA). RNA extraction from MVs was performed using the mirVana isolation We recently demonstrated that MVs released by EPCs are internalized into endothelial cells and activate an kit (Ambion, Austin, TX). RNA was analyzed by Agilent 2100 bioanalyzer (Agilent Tech. Inc., Santa angiogenic program by horizontal transfer of mRNAs (18) .
The aim of this study was to evaluate the effects of Clara, CA). In situ hybridization was performed on MVs using a miRCURY LNA detection probe against micro-EPC-derived MVs on islet angiogenesis, insulin secretion, and islet endothelial-leukocyte interaction, all bio-RNA-126 (miR-126) and miR-296 according to the manufacturer (Exiqon, Vedbaek, Denmark). The probe logical events crucial for transplanted islet engraftment and survival.
used was biotinylated at 5′ of its sequence and a scramble-miR probe (5′-biotin) was used as control (16). miR-
MATERIALS AND METHODS
126 and miR-296 expression levels were analyzed by Human Islet and Islet-Derived Endothelial qRT-PCR in a 48-well StepOne TM Real Time System Cell Isolation (Ambion): 200 ng of RNA was reverse-transcribed and the cDNA was used to detect and quantify miR-126 and For the present study, we used islets discarded from the miR-296 by qRT-PCR using the miScript SYBR Green clinical transplant for insufficient islet mass. Authorization PCR Kit (Qiagen, Valencia, CA). In selected experifor islet purification from deceased donors was obtained ments, MVs were labeled with the red fluorescent dye from the Piedmont Region Healthcare and Italian National PKH26 (Sigma Aldrich, St. Louis, MO) or treated with Transplant Centre (CNT). Ten different preparations of 1 U/ml RNase (Ambion) for 3 h at 37°C. After RNase islets were prepared following the Ricordi method (41) .
treatment the reaction was stopped by addition of 10 U/ Islet endothelial cell lines (IECs) were generated and charml RNase inhibitor (Ambion) and MVs were washed by acterized as previously described (4) .
ultracentrifugation (18) . The efficacy of RNase treat-EPC Isolation and Characterization ment was evaluated by MV-RNA analyses by Agilent EPCs were isolated from peripheral blood mononuclear 2100 bioanalyzer (Agilent). In addition, RNA extracted cells (PBMCs) of healthy donors by density centrifugation, from RNase-treated and untreated MVs was labeled by seeded on type I collagen-coated plates (48) , and characoligo dT-driven retrotranscription and analyzed on 0.6% terized on the basis of fluorescence-activated cell sorting agarose gel showing the complete degradation of RNA (FACS) analysis showing the expression of stem and by RNase (18) . endothelial markers and of the uptake of 1,1′-dioctadecylInternalization of MVs in Human Islets and IECs 3,3,3′,3′-tetramethylindocarbocyanine-labeled acetylated low-density lipoprotein, as previously described (3, 18) .
Islets (500 IEQ) cultured in microgravity and IECs seeded on six-well plates were incubated with 10 µg/ml IEC and EPC Lentiviral Infection labeled MVs. MV internalization was evaluated by confoIECs and EPCs were transduced with a lentivector cal microscopy (Zeiss LSM 5 PASCAL, Jena, Germany) carrying a CMV-GFP (green fluorescent protein) and FACS in the presence or absence of 1 µg/ml blockexpression cassette (13). Infected cells were termed ing antibodies directed to αVβ3 integrin (BioLegend), IEC-GFP and EPC-GFP and characterized by FACS and α4 integrin, α5 integrin (Chemicon Int., Temecula, CA), immunofluorescence. The EPC-GFP cells were used CD29, or L-selectin (Becton Dickinson). In selected only for experiments of microchimerism.
experiments, IECs were engineered to knock-down CD40 by small interfering RNA (siRNA) (Santa Cruz Islet-EPC Microchimerism Biotech.). MV internalization was also evaluated in the Microchimerism between islets [1,000 islet equivaendothelial cell line H-END transfected with α(1,3/4)-lent (IEQ)] and EPC-GFP (1 × 10 6 cells) was performed fucosyltransferase (H-END fucosyl) or control vector in microgravity by using the Rotary cell culture system (H-END cep) (7). (Synthecon, Houston, TX).
Assessment of Insulin Secretory Response, Isolation and Characterization of MVs From EPCs
Islet Viability, and Caspase-3 Activity MVs were obtained from supernatants of EPCs by ultracentrifugation (Optima L-90K, Beckman Coulter, Stimulation index (SI) was obtained from protein normalized (Bradford method) values of insulin secreFullerton, CA) and characterized as previously described (18) . Antigen expression on MVs was studied by FACS tion between low-and high-glucose islet challenge at different time points (5). using antibodies directed to CD14, CD34, CD42b, Lselectin, P-selectin, CD154 (Dako, Copenhagen, DenControl and MV-stimulated islets were challenged with Krebs-Ringer bicarbonate buffer (KRBB, pH 7.35) mark), α4 integrin (Becton Dickinson, San Jose, CA), containing 0.5% bovine serum albumin (BSA; Sigma) for each experimental group were examined. Animal studies were approved and conducted in accordance with under low-glucose concentration conditions (2.8 mM) and with high-glucose concentration (28 mM Apoptosis. IECs were subjected to terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) tracer (Invitrogen, Carlsbad, CA). Cells (50 × 10 6 /ml) were added to IECs previously incubated with vehicle assay (Chemicon Int.). Samples were analyzed under a fluorescence microscope and green-stained apoptotic alone or 20 ng/ml tumor necrosis factor-α (TNF-α) and 20 ng/mL interferon-γ (IFN-γ) cytokines (Sigma Aldrich) cells were counted in 10 nonconsecutive microscopic fields. In all assays, IECs were incubated with 10 µg/ml in the presence or absence of 10 µg/ml MVs. PBMC adhesion to IECs was also performed in the presence of MVs in the presence or absence of 10 ng/ml rapamycin, 0.1 mM wortmannin, 10 µM L-nitro-arginine methyl MVs pretreated with 1 µg/ml blocking antibody against L-selectin (Becton Dickinson) or with 1 µg/ml CD40-ester (L-NAME), or 10 µM D-nitro-arginine methyl ester (D-NAME) (all from Sigma Aldrich). In selected murine immunoglobulin (Ig) fusion protein (CD40 fp) (Alexis Bioch., San Diego, CA) (15) .
experiments MVs were pretreated with 1 U/ml RNase.
Gene Array Analysis Endothelial Outgrowth From Islets
Cell outgrowth from islets (500 IEQ) in the presence Human GEarray kit for the study of angiogenesis markers (SuperArray Inc., Bethesda, MD) was used to of vehicle alone or 10 µg/ml MVs was studied under a Nikon microscope system for living cell analysis. In characterize the gene expression profile of IECs incubated with vehicle alone versus 10 µg/ml MVs for 48 h. Microselected experiments, rapamycin (10 ng/ml) or MVs pretreated with 1 U/ml RNase were used. A medium conarray data are deposited on European Bioinformatic Institute (EBI) website (http://www.ebi.ac.uk/microarray-as/ taining endothelial growth factors was used as positive control for cell outgrowth (14). Endothelial phenotype ae/) as E-MEXP-2511 (experiments archive code).
of outgrowing cells was confirmed by immunostaining
Western Blot Analysis for von Willebrand factor (vWF) (Dako), CD31, vascular endothelial growth factor receptor-2 (VEGFR2 or IEC protein lysates (30 µg) were subjected to 4-15% gradient sodium dodecyl sulphate-polyacrylamide gel KDR), and CD105 (R&D Systems, Minneapolis, MN).
electrophoresis (SDS-PAGE) and electroblotted onto Xenografts in Severe Combined Immunodeficient nitrocellulose membranes. Primary antibodies directed (SCID) Mice
to Akt (Upstate, Charlottesville, VA), phosphorylated (P)-Akt and P-eNOS (endothelial nitric oxide synthase; Islets (1,000 IEQ) or IEC-GFP (10 4 cells) were mixed to 500 µl Matrigel (Becton Dickinson) in the presence Cell Signalling, Beverly, MA), eNOS, and actin (Santa Cruz Biotech.) were used. of vehicle alone or 10 µg/ml MVs pretreated or not with 1 U/ml RNase and implanted subcutaneously into the Knock-Down of Dicer in EPCs scruff region of the neck of SCID mice. After 7 days, mice were sacrificed and Matrigel plugs were retrieved Knock-down of Dicer in EPCs was performed by a specific siRNA according to the manufacturer (Santa for histology and immunohistochemistry. Six animals Cruz Biotech.). An irrelevant siRNA was used as conessential for leukocyte adhesion (3) such as α4 and β1 integrin, CD154 (CD40-L), and L-selectin (Fig. 1F ). trol. Western blot for Dicer expression was performed by using an anti-Dicer polyclonal antibody (Abcam, MVs did not express HLA class I and class II and markers of platelets (P-selectin, CD42b) and monocytes Cambridge, UK). MVs were collected by supernatants of engineered cells at day 4 after transfection and used (CD14) (Fig. 1F ). MVs carried different RNAs enriched in small RNAs including miRNAs as seen by bioanafor proliferation and angiogenesis assays on IECs.
lyzer (Fig. 1G) . By in situ hybridization ( Fig. 1H -J) and
Transfection of IECs With miR-126
qRT-PCR (Fig. 1K ) the proangiogenic miR-126 and and miR-296 AntagomiRs miR-296 were detected within MVs. As seen in Figure  Oligonucleotide inhibitors (100 pmol) (antagomiRs, 1K, RNase pretreatment of MVs abated the expression anti-miR-126, and anti-miR-296) (Ambion) were transof miR-126 and miR-296. fected into IECs seeded on six-well plates by using 4 µl MV Internalization in β-Cells Sustained Insulin lipofectamines 2000 (Invitrogen). IECs were also transSecretion and Viability fected with a predesigned 5-carboxyfluorescein (FAM)-conjugated anti-miR without biological activity as control.
Confocal microscopy analysis showed the internalAntagomiR-transfected IECs were incubated with 10 ization of PKH26-labeled MVs into β-cells as detected µg/ml MVs in proliferation and angiogenesis assays.
by costaining with insulin and glucose transporter-2 (GLUT-2) ( Fig. 2A ). However, internalization was not Statistical Analysis β-cell specific as MVs were also detectable in glucagonAll data of different experimental procedures are positive cells ( Fig. 2A were internalized into islet endothelium as assessed by islet surface and grew, forming chimeric micro-organcostaining with the endothelial markers CD31 and oids containing dithizone-stained islets (Fig. 1A, B) . VEGFR2 (KDR) (Fig. 2A) . These results were con-EPC-islet chimeras showed a significant increase of insufirmed by incorporation of MVs in different lines of isolin secretion compared to islets alone (SI 2.83 ± 0.67 lated IECs as shown by confocal microscopy ( Fig. 2D ) EPC-islet chimeras vs. 1.87 ± 0.32 islets alone at day 2).
and FACS (Fig. 2E) . The selective blockade of α4 inteSimilar results were obtained incubating islets with supergrin, β1 integrin, and L-selectin induced a significant natants of EPCs (SI 3.02 ± 0.81 islet-EPC supernatants decrease of MV internalization into IECs (Fig. 2E) . vs. 1.94 ± 0.51 islets alone at day 2), suggesting a paraMoreover, MV internalization was decreased in IECs crine effect. The use of lentivirus-infected EPC-GFP were engineered to knock-down CD40 by specific siRNA limited only to the experiments of microchimerism.
( Fig. 2F ) and in an endothelial cell line (H-END) not Characterization of EPC-Derived MVs expressing fucosylated residues that bind to L-selectin (Fig. 2G ). We investigated whether MVs obtained from the supernatants of EPCs may account for this paracrine MVs Inhibited PBMC Adhesion to IECs effect. Transmission (Fig. 1C, D) and scanning (Fig. 1E) electron microscopy showed the spheroid morphology
The addition of 10 µg/ml MVs significantly inhibited spontaneous and cytokine-induced PBMC adhesion to of MVs. Whereas a small percentage of MVs (8-10%) showed a size around 1 µm, the majority of them ranged IECs (Fig. 3A) . A fusion protein able to inhibit CD40-CD154 interaction (CD40fp) or a blocking monoclonal between 60 and 130 nm. By FACS analysis, MVs were detectable under the 1-µm beads and expressed the antibody directed to L-selectin significantly reduced PBMC adhesion (Fig. 3B) . Moreover, MVs significantly hematopoietic stem cell marker CD34 and molecules reduced PBMC adhesion to the endothelial cell line (HRNase pretreatment significantly reduced the number of MV-induced capillary-like structures (Fig. 6C, D) . END) engineered to overexpress L-selectin ligands (Fig.  3B) . These results suggest a crucial role for CD40 and Moreover, rapamycin (10 ng/ml) did not completely abrogate the angiogenic effect of MVs (Fig. 6D) : the L-selectin expressed on MVs in the inhibition of PBMC adhesion to IECs. phosphoinositide 3-kinase (PI3K) inhibitor wortmannin (0.1 mM) and the NOS inhibitor L-NAME (10 µM) but MVs Induced Endothelial Outgrowth From Islets not the inactive enantiomer D-NAME (10 µM) significantly reduced the number of capillary-like structures In comparison to vehicle alone (Fig. 3C) , 10 µg/ml MVs induced cell outgrowth from islets detectable after induced by MVs (Fig. 6D ). 24 h (Fig. 3D ) and enhanced after 96 h (Fig. 3E) (Fig. 3F) and showed a typical endothelial phenotype expressing vWF (Fig. 3G) ,
The baseline migration rate of IECs studied by time-VEGFR2 (Fig. 3H), CD31 (Fig. 3I) , and CD105 (Fig. 3J) .
lapse recording microscopy remained stable for the whole period of observation never exceeding 5-6 µm/h Effect of Rapamycin and RNase Pretreatment (Fig. 6E) .
MVs significantly increased cell motility (Fig. on MV-Induced Endothelial Outgrowth From Islets
6E). In addition, MVs significantly increased IEC prolifRapamycin (10 ng/ml) completely abrogated the islet eration (not shown) and inhibited apoptosis (Fig. 6F ). endothelial outgrowth stimulated by growth factorRNase pretreatment (1 U/ml) abrogated such effects enriched medium (Fig. 3K) . By contrast, the same dose (Fig. 6D, F ). The incubation with rapamycin, wortmanof rapamycin did not completely abolish MV-induced nin, and L-NAME but not D-NAME significantly endothelial outgrowth (Fig. 3K) . In addition, pretreatdecreased MV-induced IEC angiogenesis (Fig. 6D) , ment of MVs with 1 U/ml RNase markedly inhibited migration (Fig. 6E) , proliferation (not shown), and apoendothelial cell outgrowth, suggesting a horizontal RNA ptosis resistance (Fig. 6F) . transfer (Fig. 3K) .
Pathways Involved in MV-Induced IEC Angiogenesis MVs Induced an Early Vascularization of Human Islets
MVs enhanced the IEC gene expression of endotheXenotransplanted in SCID Mice lial differentiation sphingolipid G-protein-coupled The effect of MVs on islet neoangiogenesis was evalreceptor (EDG-1), tyrosine kinase receptor ephrin B4, uated in vivo after subcutaneous xenotransplantation of fibroblast growth factor-receptor (FGF-R), VEGF-R2, islets within Matrigel in SCID mice (14). In the presence transforming growth factor-β-receptor (TGF-β-R), α5 of MVs, transplanted islets showed an early (7 days) and β3 proangiogenic integrins, fibronectin-1, CD31, increase of vascular density as detected by hematoxylin/ and tie-2 specific endothelial markers and eNOS. In eosin and CD31 immunostaining (Fig. 4A) . The evaluaaddition, MV-stimulated IECs showed the downregulation of total area of neoformed vessels within islets contion of the antiangiogenic factors thrombospondin-1 firmed a significant increase of angiogenesis after MV (TSP-1) and 2 (TSP-2) (Fig. 7A) . Western blot analysis stimulation (Fig. 4B) . Pretreatment of MVs with 1 U/ml showed the phosphorylation of Akt and the enhanced RNase significantly reduced islet revascularization (Fig. expression and phosphorylation of eNOS in IECs incu-4A, B). Insulin staining was maintained in all experibated with MVs (Fig. 7B ). mental conditions (Fig. 4A) .
Role of miRNAs in MV-Induced IEC Angiogenesis MVs Enhanced In Vivo and In Vitro IEC Angiogenesis
In the presence of MVs, IEC-GFP xenografts in To study the role of miRNAs in MV-induced IEC angiogenesis, we engineered EPCs to knock-down SCID mice (14) showed a marked enhancement of proliferation and formation of neovessels as detected by Dicer, the intracellular enzyme essential for miRNA synthesis (Fig. 8) . We found that MVs derived from hematoxylin/eosin staining (Fig. 5A ) and fluorescence analysis (Fig. 5B) . Moreover, MVs induced a significant Dicer siRNA-EPCs but not control siRNA-EPCs showed a significant decrease of proliferative (Fig. 8A ) increase of total area of vessels formed within Matrigel (Fig. 5C ). The in vivo IEC angiogenesis was signifiand angiogenic (Fig. 8B ) effects on IECs. For these experiments, we used MVs derived from EPCs with the cantly inhibited by pretreatment of MVs with 1 U/ml RNase (Fig. 5A, C) .
maximal knock-down of Dicer 4 days after transfection (Fig. 8C) . qRT-PCR analysis showed reduced levels of In vitro, IEC-GFP spontaneously formed capillarylike structures on Matrigel (Fig. 6A) . The addition of miR-126 and miR-296 in MVs derived from siRNA Dicer but not from control siRNA EPCs (Fig. 8D) . IECs MVs accelerated and enhanced this process (Fig. 6B ).
were transfected with selective antagomiRs (antagomiRis still matter of debate. Some authors showed that the proangiogenic potential of these cells derived from the 126 or antagomiR-296) or a FAM-conjugated control antagomiR (Fig. 8E) . A-miR-126 and A-miR-296 signifcirculation may be due to the contamination with monocytes and platelet-derived products (38). To avoid conicantly reduced IEC proliferation (Fig. 8F ) and angiogenesis (Fig. 8G) . No effect was detected by using the tamination, we used MVs isolated from EPCs after three passages in culture. The cells used and the derived MVs FAM-conjugated control antagomiR (not shown). The addition of MVs overcame the inhibitory effects of both expressed markers of stem cells (CD34, CD133) and of endothelium (VEGFR2, CD31) but not of monocytes antagomiRs (Fig. 8E, F) .
(CD14) and platelets (P-selectin, CD41, CD42b). It has been suggested that EPCs do not act via a DISCUSSION direct trans-differentiation into mature endothelial cells, but rather by secreting angiogenic growth factors or In this study, we demonstrated that EPC-derived MVs enhanced transplanted islet neoangiogenesis.
other active molecules (46). The exogenous infusion of EPCs or their mobilization from the bone marrow Several studies addressed the relevance of angiogenesis in the early events occurring after intraportal infufavored the recovery of damaged β-cells in murine models of islet transplantation (17, 29 ). Here we found that sion of islets. Purified islets maintain viable native endothelial cells able to trigger the revascularization by EPCs in microgravity formed with islets micro-organoids with enhanced viability, insulin secretion, and angiforming chimeric structures with the recipient vessels (10). Endogenous and exogenous factors may influence ogenic properties. Since EPC supernatants mimicked the same effects on islets, it is conceivable that paracrine islet endothelium viability (4, 34) . Several proangiogenic growth factors (19, 45) and composite islet-endothelial factors secreted from EPCs play a role. Recent studies suggested a paracrine action of MVs that may act as cell grafts were shown to improve islet vascularization and to inhibit the inflammatory response (23, 24) .
mediators of cell-to-cell communication (12). We previously demonstrated that MVs released from EPCs trigWe evaluated whether EPCs were capable to form chimeric micro-organoids with islets. EPCs have been ger angiogenesis by a horizontal transfer of mRNA (18) . MVs are released by several cell types including plateshown to be protective on ischemia-reperfusion injury and cardiovascular diseases (21, 28) and T lymphocytes, monocytes, and dendritic cells and Moreover, MVs expressed CD154 able to bind the costimulatory molecule CD40 which was expressed by IECs display pleiotropic effects (1, 8, 20, 32, 35, 36, 42 ).
Herein we demonstrated that EPC-derived MVs are (14). These receptors not only mediated the internalization of MVs but, by competing with the molecules internalized in β-cells and islet endothelium sustaining insulin secretion and angiogenesis. MV uptake was expressed on leukocytes, may interfere with leukocyte adhesion to endothelium. This could limit the triggering mediated by specific cell membrane receptors such as α4 and β1 integrins, L-selectin, and CD154 (CD40-of inflammation and/or allo-and autoimmmune-mediated injury in transplanted islets. Ligand). We previously demonstrated that EPCs express L-selectin and that this molecule is essential for their
We also found that MVs enhanced in vitro proliferation, resistance to apoptosis, migration of IECs, and homing at the sites of vascular injury (3). Here we showed that EPC-derived MVs internalized into target endothelial outgrowth from islets. Gene array analysis of IECs stimulated with MVs showed an increased endothelial cells via L-selectin by binding to fucosylated residues or other oligosaccharidic ligands known to be expression of angiogenesis-related molecules. In particular, MVs triggered the activation of PI3K/Akt and upregulated after ischemia-reperfusion injury (11). The mTOR inhibitor rapamycin (10 ng/ml), the phosphate inositol 3 kinase (PI3K)-inhibitor wortmannin (0.1 mM), and the nitric oxide synthase (NOS) inhibitor L-NAME (10 µM) significantly reduced the angiogenic effect of MVs (#p < 0.05 MV + rapamycin, MV + wortmannin, or MV + L-NAME vs. MV). Incubation of IECs with the inactive enantiomer D-NAME (10 µM) did not alter MV angiogenic effect. The mTOR, PI3K, and NOS pharmacologic inhibition did not reach the reduction of the angiogenic effect observed by pretreatment of MVs with RNase but the difference was not statistically significant. (E, F) Effect of MVs on migration (E) and inhibition of IEC apoptosis induced by serum deprivation (F). In comparison to vehicle alone, MVs induced a significant increase of migration (E) and inhibition of apoptosis (F) (*p < 0.05 MV vs. vehicle alone). Pretreatment with 1 U/ml RNase significantly reduced MV-induced migration (E) and inhibition of apoptosis (F) (#p < 0.05 MV + RNase vs. MV). The mTOR inhibitor rapamycin (10 ng/ml), the PI3K inhibitor wortmannin (0.1 mM), and the NOS inhibitor L-NAME (10 µM) significantly reduced the migratory (E) and antiapoptotic (F) effects of MVs (#p < 0.05 MV + rapamycin, MV + wortmannin, or MV + L-NAME vs. MV). Incubation of IECs with the inactive enantiomer D-NAME (10 µM) did not alter MV-induced migration and inhibition of apoptosis. The mTOR, PI3K, and NOS pharmacologic inhibition did not reach the reduction of migration and resistance to apoptosis observed by pretreatment of MVs with RNase ( †p < 0.05 MV + RNase vs. MV + rapamycin, MV + wortmannin, or MV + L-NAME). For all assays, three independent experiments were performed with similar results. eNOS signaling pathways. MVs released by EPCs were EDG-1 is the receptor for sphingosine 1-phosphate (S1P), which is known to activate the endothelial isopreviously shown to shuttle specific mRNAs associated with PI3K/Akt and eNOS pathways (18) . MVs also form of eNOS, thus inducing angiogenesis (22) . Moreover, MV-stimulated IECs showed increased levels of induced in IECs the upregulation of ephrin B4 and EDG-1. Ephrins and their relative tyrosine kinase recep-CD31 (platelet/endothelial cell adhesion molecule 1; PECAM-1), a molecule known to inhibit endothelial tors have been identified in islet endothelium and were deeply involved in cell motility and adhesion (26) . apoptosis, and a reduced expression of TSP-1. TSP-1 is an inhibitor of angiogenesis, which also promotes apomiR-126 and miR-296 miRNAs (47) . miRNAs are small noncoding RNAs able to modulate protein transduction ptosis in activated endothelial cells (27) . We have previously shown that TSP-1 is upregulated in IECs in (31) . The role of miRNAs shuttled by MVs in islet angiogenesis was inferred by experiments with MVs derived response to rapamycin (14). Moreover, TSP-1 knockout mice presented islet hyperplasia characterized by an from EPCs previously subjected to the knock-down of Dicer. Dicer is an intracellular enzyme essential for increased blood vessel density (33) .
The significant reduction of MV activities after treatmiRNA production (30) . In Dicer-silenced MVs, the expression of the angiogenic miR-126 and miR-296 was ment with RNase suggests a putative horizontal transfer of RNAs. We previously characterized the mRNAs shutdecreased and the proliferation and angiogenesis of IECs was significantly reduced. On the other hand, tled by EPC-derived MVs (18) . In the present study, we found that MVs were enriched in the angiogenic MV-containing miR-126 and miR-296 were able to
